Association of Biotechnology Led Enterprises

News

GSK and Vir Biotechnology start Phase 2/3 study of COVID-19 Antibody Treatment

Phase 2/3 COMET-ICE study will investigate the safety and efficacy of antibody treatment in preventing hospitalization due to COVID-19

Sep 03, 2020

By : Team ABLE

Winning Over Covid-19: Dr Kiran Mazumdar-Shaw’s Experience

ABLE non-executive Chairperson and Biocon executive chairperson Kiran Mazumdar-Shaw, who recently tested COVID-19 positive and recovered subsequently, says that leveraging science to manage the virus is the only reliable way ahead. Here is the first person account from her blog.

Sep 03, 2020

By : Kiran Mazumdar-Shaw

Bharat Biotech Prepares for Phase 2 human clinical trials of Covaxin

Phase 1 human trial encountered ‘no side effects’: Dr E Venkata Rao, Principal Investigator

Sep 03, 2020

By : Team ABLE

2 home-made Bt Brinjal varieties from Beejsheetal get conditional nod for field trials in 8 states

After 11 years, the government is taking initial tentative steps towards allowing introduction of first genetically modified food crop in the country. “It is nice to know that the GM brinjal varieties developed by Beejsheetal has been given regulatory approval for field trials,” commented Dr K K Narayanan, executive council member of ABLE and chairman of Kottaram Agrofoods.

Sep 03, 2020

By : Narayanan Suresh